We are live on
!
Find out more
LHDX
Lucira Health, Inc. Common Stock
LHDX
LHDX
Delisted
LHDX was delisted on the 3rd of March, 2023.
6 hedge funds and large institutions have $1.46M invested in Lucira Health, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
41% more capital invested
Capital invested by funds: $1.04M → $1.46M (+$422K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
79% less funds holding
Funds holding: 29 → 6 (-23)
92% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 25
Holders
6
Holders Change
-23
Holders Change %
-79.31%
% of All Funds
0.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
1
Reduced
–
Closed
25
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$6K
Top Buyers
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$26.2K |
| 2 |
Barclays
London,
United Kingdom
|
+$1.03K |
| 3 |
CS
Clear Street
New York
|
+$356 |
Top Sellers
| 1 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$80.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$69.3K |
| 3 |
Citigroup
New York
|
-$48.5K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$30.1K |
| 5 |
Morgan Stanley
New York
|
-$23.1K |